Literature DB >> 31393608

Prospective cohort study of appendicectomy for treatment of therapy-refractory ulcerative colitis.

M E Stellingwerf1, S Sahami1, D C Winter2, S T Martin2, G R D'Haens3, G Cullen2, G A Doherty2, H Mulcahy2, W A Bemelman1, C J Buskens1.   

Abstract

INTRODUCTION: Appendicectomy may reduce relapses and need for medication in patients with ulcerative colitis, but long-term prospective data are lacking. This study aimed to analyse the effect of appendicectomy in patients with refractory ulcerative colitis.
METHODS: In this prospective multicentre cohort series, all consecutive patients with refractory ulcerative colitis referred for proctocolectomy between November 2012 and June 2015 were counselled to undergo laparoscopic appendicectomy instead. The primary endpoint was clinical response (reduction of at least 3 points in the partial Mayo score) at 12 months and long-term follow-up. Secondary endpoints included endoscopic remission (endoscopic Mayo score of 1 or less), failure (colectomy or start of experimental medication), and changes in Inflammatory Bowel Disease Questionnaire (IBDQ) (range 32-224), EQ-5D™ and EORTC-QLQ-C30-QL scores.
RESULTS: A total of 28 patients (13 women; median age 40·5 years) underwent appendicectomy. The mean baseline IBDQ score was 127·0, the EQ-5D™ score was 0·65, and the EORTC-QLQ-C30-QL score was 41·1. At 12 months, 13 patients had a clinical response, five were in endoscopic remission, and nine required a colectomy (6 patients) or started new experimental medical therapy (3). IBDQ, EQ-5D™ and EORTC-QLQ-C30-QL scores improved to 167·1 (P < 0·001), 0·80 (P = 0·003) and 61·0 (P < 0·001) respectively. After a median of 3·7 (range 2·3-5·2) years, a further four patients required a colectomy (2) or new experimental medical therapy (2). Thirteen patients had a clinical response and seven were in endoscopic remission. The improvement in IBDQ, EQ-5D™ and the EORTC-QLQ-C30-QL scores remained stable over time.
CONCLUSION: Appendicectomy resulted in a clinical response in nearly half of patients with refractory ulcerative colitis and a substantial proportion were in endoscopic remission. Elective appendicectomy should be considered before proctocolectomy in patients with therapy-refractory ulcerative colitis.
© 2019 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31393608     DOI: 10.1002/bjs.11259

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Inflammation of the appendix in ulcerative colitis - Does it have a predictive value?

Authors:  Fernando Magro; Maria Manuela Estevinho; Roger Feakins
Journal:  United European Gastroenterol J       Date:  2021-12-02       Impact factor: 4.623

2.  Clinical relevance of endoscopic peri-appendiceal red patch in ulcerative colitis patients.

Authors:  Maud A Reijntjes; Lianne Heuthorst; Krisztina Gecse; Aart Mookhoek; Willem A Bemelman; Christianne J Buskens
Journal:  Therap Adv Gastroenterol       Date:  2022-06-28       Impact factor: 4.802

Review 3.  When disease extent is not always a key parameter: Management of refractory ulcerative proctitis.

Authors:  Georgios Michalopoulos; Konstantinos Karmiris
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-12-11

4.  A Quality-of-Life Evaluation Study Assessing Health-Related Quality of Life in Patients Receiving Medicinal Cannabis (the QUEST Initiative): Protocol for a Longitudinal Observational Study.

Authors:  Margaret-Ann Tait; Daniel S J Costa; Rachel Campbell; Richard Norman; Stephan Schug; Claudia Rutherford
Journal:  JMIR Res Protoc       Date:  2021-11-24

5.  High prevalence of ulcerative appendicitis in patients with ulcerative colitis.

Authors:  Lianne Heuthorst; Aart Mookhoek; Manon E Wildenberg; Geert R D'Haens; Willem A Bemelman; Christianne J Buskens
Journal:  United European Gastroenterol J       Date:  2021-11-09       Impact factor: 4.623

6.  Appendectomy and risk for inflammatory bowel disease: effect of age and time post appendectomy - a cohort study.

Authors:  Canisius Fantodji; Prévost Jantchou; Marie-Elise Parent; Marie-Claude Rousseau
Journal:  BMJ Open Gastroenterol       Date:  2022-07

Review 7.  Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.

Authors:  Ross J Porter; Mark J Arends; Antonia M D Churchhouse; Shahida Din
Journal:  J Crohns Colitis       Date:  2021-12-18       Impact factor: 9.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.